Author Archive: BIOtechNOW Editor

The Next Step: How Companies Build Successful Therapeutic Franchises from the Ground Up

Building a new franchise in a therapeutic from scratch poses a host of challenges, from whether to take the risk of entering a new area at all to whether and how to partner strategically with another company. It’s a challenge for both the biggest biopharma companies and emerging biotechs to evaluate how and when to enter new therapeutic areas and to try to ensure that their efforts will not only help patients in need but Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Legislative Best Practices in Support of Bioscience Economic Development

shutterstock_26191726

Despite a difficult economic environment the past couple years, states across the country have found that a number of factors are key to attracting new bioscience industry and helping current bioscience companies thrive in their states. In particular, state initiatives that focus on capital formation, workforce development and a supportive business environment have been key to the success of states that want to grow their bioscience industry In a session titled “Legislative Best Practices in Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Business Development and Building the Relationship After BIO

Luigi LaCorte, GSK

There is a great energy here at BIO, and you can feel it as you walk through the Business Forum and see everyone talking, sharing information, and exchanging business cards.  Nowhere else do you feel that buzz of excitement that comes from sharing innovative ideas and knowing the person you are speaking with feels the same.  But what happens next?  BIO is just the beginning. What happens after BIO is just as important as making Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Pharma R&D Pipeline Value Jumps 18 Percent to $493 Billion

World Preview 2015, Outlook to 2020

The pharmaceutical industry continues its impressive two-year growth with no signs of slowing down according to new consensus forecast data from the annual state of the industry report, “World Preview 2015, Outlook to 2020” from market intelligence firm, Evaluate. The report, which launched today at the 2015 BIO International Convention, found that worldwide prescription drug sales are expected to grow at 4.8 percent a year until 2020 – growth that is being fueled by the Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Prepare and Protect from Biological Threats

ebola

Yesterday the Alliance for Biosecurity hosted a panel that outlined the important role played by industry in preparedness against biosecurity threats. The session, Learning from the Ebola Outbreak: Sustaining and Strengthening the Public-Private Partnership and Ensuring Preparedness, included government funders of product development and procurement and representatives from companies engaged in the development of medical countermeasures. The Alliance is a coalition of more than a dozen biopharmaceutical companies and academic institutions that advocates for public Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,